We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to trans... Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. Show more
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of...
MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resistance mechanismValidation of novel translational...
Advanced OTX-2002 in MYCHELANGELO™ I trial; initial cohorts demonstrated encouraging disease control rate in late-stage HCC patientsEstablished a research collaboration with Novo Nordisk to...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of...
CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.19 | -7.91666666667 | 2.4 | 2.5399 | 2.2001 | 267819 | 2.36553149 | CS |
4 | -1.42 | -39.1184573003 | 3.63 | 3.63 | 2.2001 | 344583 | 2.76543989 | CS |
12 | -1.12 | -33.6336336336 | 3.33 | 4.4599 | 2.2001 | 401196 | 3.55891374 | CS |
26 | 0.56 | 33.9393939394 | 1.65 | 6.3 | 1.3 | 1223589 | 4.58976182 | CS |
52 | -4.92 | -69.0042075736 | 7.13 | 10.09 | 1.3 | 691655 | 4.62098127 | CS |
156 | -19.89 | -90 | 22.1 | 31.41 | 1.3 | 321209 | 5.64896989 | CS |
260 | -19.89 | -90 | 22.1 | 31.41 | 1.3 | 321209 | 5.64896989 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions